Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Blood (2009) 114 (22): 2375.

https://doi.org/10.1182/blood.V114.22.2375.2375

Published: 2009

Journal Articles

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Blood (2009) 114 (22): 2341.

https://doi.org/10.1182/blood.V114.22.2341.2341

Published: 2009

Journal Articles

Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells.

Giovanni Fernando Torelli, Roberta Maggio, Nadia Peragine, Sabina Chiaretti, Maria Stefania De Propris, Maria Screnci, Barbarella Lucarelli, Maria Grazia Mascolo, Anna Paola Iori, Gabriella Girelli, Anna Guarini, Robert Foà

Blood (2009) 114 (22): 4085.

https://doi.org/10.1182/blood.V114.22.4085.4085

Published: 2009

Journal Articles

Efficacy and Safety of a First-Line Combined Therapeutic Approach for Young CLL Patients Stratified According to the Biological Prognostic Features: First Analysis of the GIMEMA Multicenter LLC0405 Study

Blood (2008) 112 (11): 3167.

https://doi.org/10.1182/blood.V112.11.3167.3167

Published: 2008

Journal Articles

BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels

Francesco Libotte, Maria Rosaria Ricciardi, Elisabetta Calabrese, Cinzia De Benedictis, Sara Santinelli, Paola Bergamo, Samantha Decandia, Anna Levi, Ali Fathi Mohamad, Vincenzo Federico, Michele Milella, Robert Foà, Agostino Tafuri, Maria Teresa Petrucci

Blood (2008) 112 (11): 5159.

https://doi.org/10.1182/blood.V112.11.5159.5159

Published: 2008

Journal Articles

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways

Maria Rosaria Ricciardi, Michele Milella, Francesco Libotte, Elisabetta Calabrese, Paola Bergamo, Sara Santinelli, Samantha Decandia, Cinzia De Benedictis, Anna Levi, Robert Foà, Agostino Tafuri, Maria Teresa Petrucci

Blood (2008) 112 (11): 5161.

https://doi.org/10.1182/blood.V112.11.5161.5161

Published: 2008

Journal Articles

Inherited and Acquired Thrombophilic Abnormalities in Patients Aged <20 Years with Bcr-Abl Negative Chronic Myeloproliferative Disorders

Fiorina Giona, Angela Amendola, Giovanna Palumbo, Patrizia Pignoloni, Antonio Chistolini, Maria Luisa Moleti, Robert Foà, Maria Gabriella Mazzucconi

Blood (2008) 112 (11): 5249.

https://doi.org/10.1182/blood.V112.11.5249.5249

Published: 2008

Journal Articles

Line Treatment of Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study

Blood (2008) 112 (11): 305.

https://doi.org/10.1182/blood.V112.11.305.305

Published: 2008

Journal Articles

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

Blood (2008) 112 (11): 3316.

https://doi.org/10.1182/blood.V112.11.3316.3316

Published: 2008

Journal Articles

Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase (AID) Are Aberrantly Over-Expressed in BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL) Patients and Promote Genetic Instability.

Blood (2008) 112 (11): 1497.

https://doi.org/10.1182/blood.V112.11.1497.1497

Published: 2008

Journal Articles

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Fiorina Giona, Maria Caterina Putti, Maria Luisa Moleti, Mauro Nanni, Anna Maria Testi, Stefania Varotto, Enrico Marco Gottardi, Annalisa De Vellis, Vittorio Nunes, Daniela Diverio, Anna Leszl, Giuseppe Saglio, MD, Robert Foà

Blood (2008) 112 (11): 4273.

https://doi.org/10.1182/blood.V112.11.4273.4273

Published: 2008

Journal Articles

Identification and Molecular Characterization of Two Recurrent Genomic Deletions (Type A and Type B) on 7p12 in IKZF1 Gene in a Large Cohort of BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL): on Behalf of the GIMEMA ALL Working Party

Blood (2008) 112 (11): 428.

https://doi.org/10.1182/blood.V112.11.428.428

Published: 2008

Journal Articles

BCR-ABL Protein Detection by Flow Cytometry in Acute Lymphoblastic Leukemia Samples

Anna Guarini, Sara Raponi, Maria Sefania De Propris, Loredana Elia, Hobert Wai, Robert Foà

Blood (2008) 112 (11): 4859.

https://doi.org/10.1182/blood.V112.11.4859.4859

Published: 2008

Journal Articles

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Blood (2008) 112 (11): 753.

https://doi.org/10.1182/blood.V112.11.753.753

Published: 2008

Journal Articles

Comparative Gene Profiling of Acute Myeloid Leukemia (AML) and Malignant Melanoma (MEL) Cell Lines Exposed to the MEK Inhibitor PD0325901 Reveals Common Effectors of the MEK/ERK Kinase Module.

Michele Milella, MD, Sabina Chiaretti, MD, PhD, Maria R. Ricciardi, PhD, Simona Tavolaro, BSc, Ludovica Ciuffreda, PhD, Barbara Benassi, PhD, Alfonso Bellacosa, MD, PhD, Gianfranco Peluso, PhD, Paola Bergamo, MS, James A. McCubrey, PhD, Francesco Cognetti, MD, Gabriella Zupi, PhD, Robert Foà, MD, Agostino Tafuri, MD

Blood (2007) 110 (11): 3470.

https://doi.org/10.1182/blood.V110.11.3470.3470

Published: 2007

Journal Articles

Possible Role of Ozone Therapy in the Treatment of Osteonecrosis of the Jaws in Multiple Myeloma Patients.

Cristiano Gallucci, MD, Alessandro Agrillo, MD, Giorgio Iannetti, MD, Robert Foà, MD, Maria Teresa Petrucci, MD

Blood (2005) 106 (11): 3460.

https://doi.org/10.1182/blood.V106.11.3460.3460

Published: 2005

Journal Articles

Quantification of CD52 Antigen Expression by Normal and Leukemic Lymphoid Cells: Indications for Anti-CD52 Antibody Therapy?.

Anna Guarini, PhD, Maria Stefania De Propris, PhD, Stefania Intoppa, Maria Laura Milani, Alessandro Lisci, Marilisa Martinelli, BSc, Antonella Vitale, MD, Francesca Romana Mauro, MD, Robert Foà, MD

Blood (2005) 106 (11): 3918.

https://doi.org/10.1182/blood.V106.11.3918.3918

Published: 2005

Journal Articles

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Maria Teresa Petrucci, MD, Vincenza Martini, MD, Cristiano Gallucci, MD, Erica Finolezzi, MD, Anna Levi, MD, Patrizia Del Bianco, PhD, Franco Mandelli, MD, Robert Foà, MD

Blood (2005) 106 (11): 5151.

https://doi.org/10.1182/blood.V106.11.5151.5151

Published: 2005

Journal Articles

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Anna Guarini, PhD, Roberta Maggio, BSc, Maria Stefania De Propris, PhD, Nadia Peragine, Monica Messina, Elisabetta Calabrese, MD, Cristina Ariola, BSc, Giovanna Meloni, MD, Antonella Vitale, MD, Robert Foà, MD

Blood (2005) 106 (11): 1835.

https://doi.org/10.1182/blood.V106.11.1835.1835

Published: 2005

Journal Articles

Role of Extracellular Signal-Regulated Kinase-1/2 (ERK) on Complete Remission Achievement of Primary Adult Acute Lymphoblastic Leukemia Patients Enrolled in the GIMEMA Protocol LAL 2000: In Vitro Activity of the MEK Inhibithor PD98059.

Blood (2005) 106 (11): 853.

https://doi.org/10.1182/blood.V106.11.853.853

Published: 2005

NARROW

External Validation On Biological Basis of New Prognostic Index in Early Asymptomatic Chronic Lymphocytic Leukemia (CLL) Patients: The Gruppo Italiano Studio Linfomi (GISL) Experience.

Incidence of Cytogenetic Abnormalities in Newly Diagnosed Binet Stage A B-CLL and Relationship with Prognostic Biomarkers: Preliminary Results On 305 Patients Included in the Prospective O-CLL1 GISL Study.

Functional Analysis and Gene Expression Profile of Umbilical Cord Blood Regulatory T Cells.

Efficacy and Safety of a First-Line Combined Therapeutic Approach for Young CLL Patients Stratified According to the Biological Prognostic Features: First Analysis of the GIMEMA Multicenter LLC0405 Study

BCL-2/BCL-XL Inhibition in Smoldering Multiple Myeloma CD138+ Cells: Functional Effects and Protein Expression Levels

Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways

Inherited and Acquired Thrombophilic Abnormalities in Patients Aged <20 Years with Bcr-Abl Negative Chronic Myeloproliferative Disorders

Line Treatment of Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase (AID) Are Aberrantly Over-Expressed in BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL) Patients and Promote Genetic Instability.

Imatinib Mesylate Induces High Complete Cytogenetic and Molecular Response Rates in Children and Adolescents with Philadelphia Chromosome-Positive (Ph + ) Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP)

Identification and Molecular Characterization of Two Recurrent Genomic Deletions (Type A and Type B) on 7p12 in IKZF1 Gene in a Large Cohort of BCR-ABL1 -Positive Acute Lymphoblastic Leukemia (ALL): on Behalf of the GIMEMA ALL Working Party

BCR-ABL Protein Detection by Flow Cytometry in Acute Lymphoblastic Leukemia Samples

The Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Sub-Classification of Leukemia: Final Report on 3252 Cases from the International MILE Study Group

Comparative Gene Profiling of Acute Myeloid Leukemia (AML) and Malignant Melanoma (MEL) Cell Lines Exposed to the MEK Inhibitor PD0325901 Reveals Common Effectors of the MEK/ERK Kinase Module.

Possible Role of Ozone Therapy in the Treatment of Osteonecrosis of the Jaws in Multiple Myeloma Patients.

Quantification of CD52 Antigen Expression by Normal and Leukemic Lymphoid Cells: Indications for Anti-CD52 Antibody Therapy?.

Velcade an Active Agent for Multiple Myeloma Patients. Experience of a Single Center.

Dendritic Cell-Based Immunotherapeutic Strategies in Adult Acute Lymphoid Leukemia Patients Treated with Conventional Therapy or with Imatinib.

Role of Extracellular Signal-Regulated Kinase-1/2 (ERK) on Complete Remission Achievement of Primary Adult Acute Lymphoblastic Leukemia Patients Enrolled in the GIMEMA Protocol LAL 2000: In Vitro Activity of the MEK Inhibithor PD98059.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only